Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial-Reference-Cited by-同舟云学术

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial

Published:1992-09 Issue:3 Volume:16 Page:707-714
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Beuers Ulrich,Spengler Ulrich,Kruis Wolfgang,Aydemir ülker,Wiebecke Baldur,Heldwein Walter,Weinzierl Marlene,Pape Gerd R.,Sauerbruch Tilman,Paumgartner Gustav

Publisher

Wiley

Subject

Hepatology

Reference33 articles.

1. Medical Approaches to Primary Sclerosing Cholangitis

2. Ursodeoxycholic Acid

3. A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis

4. Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial

Cited by 422 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study;Clinical and Translational Gastroenterology;2024-07-01

2. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis;BMC Medical Genomics;2024-06-11

3. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis;Expert Opinion on Pharmacotherapy;2024-05-02

4. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study;2024-04-25

5. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18